BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26299961)

  • 1. Adenylylation of Gyrase and Topo IV by FicT Toxins Disrupts Bacterial DNA Topology.
    Harms A; Stanger FV; Scheu PD; de Jong IG; Goepfert A; Glatter T; Gerdes K; Schirmer T; Dehio C
    Cell Rep; 2015 Sep; 12(9):1497-507. PubMed ID: 26299961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of gyrase and topoisomerase IV on bacterial nucleoid: implications for nucleoid organization.
    Hsu YH; Chung MW; Li TK
    Nucleic Acids Res; 2006; 34(10):3128-38. PubMed ID: 16757578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptides based on CcdB protein as novel inhibitors of bacterial topoisomerases.
    Trovatti E; Cotrim CA; Garrido SS; Barros RS; Marchetto R
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6161-4. PubMed ID: 18938079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of negative DNA supercoiling: a cascade of DNA-induced conformational changes prepares gyrase for strand passage.
    Gubaev A; Klostermeier D
    DNA Repair (Amst); 2014 Apr; 16():23-34. PubMed ID: 24674625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel symmetric and asymmetric DNA scission determinants for Streptococcus pneumoniae topoisomerase IV and gyrase are clustered at the DNA breakage site.
    Leo E; Gould KA; Pan XS; Capranico G; Sanderson MR; Palumbo M; Fisher LM
    J Biol Chem; 2005 Apr; 280(14):14252-63. PubMed ID: 15659402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chirality sensing by Escherichia coli topoisomerase IV and the mechanism of type II topoisomerases.
    Stone MD; Bryant Z; Crisona NJ; Smith SB; Vologodskii A; Bustamante C; Cozzarelli NR
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8654-9. PubMed ID: 12857958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What makes a type IIA topoisomerase a gyrase or a Topo IV?
    Hirsch J; Klostermeier D
    Nucleic Acids Res; 2021 Jun; 49(11):6027-6042. PubMed ID: 33905522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic state of DNA topology is essential for genome condensation in bacteria.
    Ohniwa RL; Morikawa K; Kim J; Ohta T; Ishihama A; Wada C; Takeyasu K
    EMBO J; 2006 Nov; 25(23):5591-602. PubMed ID: 17093499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A naturally chimeric type IIA topoisomerase in Aquifex aeolicus highlights an evolutionary path for the emergence of functional paralogs.
    Tretter EM; Lerman JC; Berger JM
    Proc Natl Acad Sci U S A; 2010 Dec; 107(51):22055-9. PubMed ID: 21076033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular interactions of the CcdB poison with its bacterial target, the DNA gyrase.
    Van Melderen L
    Int J Med Microbiol; 2002 Feb; 291(6-7):537-44. PubMed ID: 11890555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual inhibition of Staphylococcus aureus DNA gyrase and topoisomerase IV activity by phenylalanine-derived (Z)-5-arylmethylidene rhodanines.
    Werner MM; Patel BA; Talele TT; Ashby CR; Li Z; Zauhar RJ
    Bioorg Med Chem; 2015 Sep; 23(18):6125-37. PubMed ID: 26320664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bacterial toxin-antitoxin module is the origin of inter-bacterial and inter-kingdom effectors of Bartonella.
    Harms A; Liesch M; Körner J; Québatte M; Engel P; Dehio C
    PLoS Genet; 2017 Oct; 13(10):e1007077. PubMed ID: 29073136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An endogenous protein inhibitor, YjhX (TopAI), for topoisomerase I from Escherichia coli.
    Yamaguchi Y; Inouye M
    Nucleic Acids Res; 2015 Dec; 43(21):10387-96. PubMed ID: 26553797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping E. coli Topoisomerase IV Binding and Activity Sites.
    El Sayyed H; Espéli O
    Methods Mol Biol; 2018; 1703():87-94. PubMed ID: 29177735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Fic-1 as an enzyme that inhibits bacterial DNA replication by AMPylating GyrB, promoting filament formation.
    Lu C; Nakayasu ES; Zhang LQ; Luo ZQ
    Sci Signal; 2016 Jan; 9(412):ra11. PubMed ID: 26814232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of peptides from bacterial ParE toxin as inhibitors of topoisomerases.
    Barbosa LC; Garrido SS; Garcia A; Delfino DB; Santos Ldo N; Marchetto R
    Eur J Med Chem; 2012 Aug; 54():591-6. PubMed ID: 22749642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vibrio cholerae ParE2 poisons DNA gyrase via a mechanism distinct from other gyrase inhibitors.
    Yuan J; Sterckx Y; Mitchenall LA; Maxwell A; Loris R; Waldor MK
    J Biol Chem; 2010 Dec; 285(51):40397-408. PubMed ID: 20952390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the nucleoid-associated protein YejK.
    Lee C; Marians KJ
    J Biol Chem; 2013 Nov; 288(44):31503-16. PubMed ID: 24043617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxin-antitoxin modules as bacterial metabolic stress managers.
    Buts L; Lah J; Dao-Thi MH; Wyns L; Loris R
    Trends Biochem Sci; 2005 Dec; 30(12):672-9. PubMed ID: 16257530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First functional characterization of a singly expressed bacterial type II topoisomerase: the enzyme from Mycobacterium tuberculosis.
    Aubry A; Fisher LM; Jarlier V; Cambau E
    Biochem Biophys Res Commun; 2006 Sep; 348(1):158-65. PubMed ID: 16876125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.